Armstrong Fleming & Moore’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,040
Closed -$257K 106
2025
Q3
$257K Buy
1,040
+5
+0.5% +$1.3K 0.12% 88
2025
Q2
$309K Buy
+1,035
New +$315K 0.17% 80
2025
Q1
Sell
-1,027
Closed -$361K 80
2024
Q4
$361K Sell
1,027
-51
-5% -$18.4K 0.22% 68
2024
Q3
$381K Buy
1,078
+41
+4% +$13.5K 0.22% 67
2024
Q2
$315K Sell
1,037
-26
-2% -$7.96K 0.2% 70
2024
Q1
$369K Buy
1,063
+2
+0.2% +$729 0.26% 70
2023
Q4
$372K Sell
1,061
-56
-5% -$18.1K 0.28% 65
2023
Q3
$343K Sell
1,117
-61
-5% -$19.2K 0.33% 62
2023
Q2
$363K Buy
+1,178
New +$342K 0.33% 60

Other funds holding ACN

Armstrong Fleming & Moore's ACN Position: Q4 2025 in Review

Armstrong Fleming & Moore sold out of Accenture (ACN) in Q4 2025, closing a stake of 1,040 shares — an estimated $257K sold.

Armstrong Fleming & Moore first reported a position in ACN in Q2 2023 and held it in 9 quarters. The position peaked at $381K in Q3 2024. 2,365 funds tracked by Wall St. Rank hold ACN as of Q4 2025.

  • Armstrong Fleming & Moore reported no remaining Accenture position as of Q4 2025 after selling out during the quarter.
  • Armstrong Fleming & Moore sold 1,040 Accenture shares in Q4 2025, an estimated $257K.
  • Armstrong Fleming & Moore first reported a position in Accenture in Q2 2023 and held it in 9 quarters.
  • Armstrong Fleming & Moore's Accenture position peaked at $381K in Q3 2024.
  • 2,365 funds tracked by Wall St. Rank held Accenture as of Q4 2025.

Based on Armstrong Fleming & Moore's 13F filing for Q4 2025, filed 16 Jan 2026.